| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 807.52B | 801.75B | 818.76B | 876.08B | 762.93B | 655.53B |
| Gross Profit | 356.75B | 357.14B | 346.46B | 393.88B | 346.83B | 298.35B |
| EBITDA | 62.34B | 62.45B | 65.77B | 125.00B | 110.08B | 87.84B |
| Net Income | 32.71B | 16.27B | 8.11B | 73.86B | 61.40B | 43.31B |
Balance Sheet | ||||||
| Total Assets | 1.37T | 1.36T | 1.35T | 998.16B | 930.63B | 820.38B |
| Cash, Cash Equivalents and Short-Term Investments | 156.91B | 149.02B | 143.09B | 105.28B | 155.48B | 250.75B |
| Total Debt | 210.35B | 144.31B | 172.76B | 45.37B | 60.12B | 38.89B |
| Total Liabilities | 429.37B | 427.36B | 403.74B | 266.93B | 262.66B | 211.02B |
| Stockholders Equity | 776.87B | 771.88B | 786.69B | 728.47B | 665.23B | 606.86B |
Cash Flow | ||||||
| Free Cash Flow | 13.86B | 6.79B | -503.00M | 8.44B | 34.07B | 67.17B |
| Operating Cash Flow | 63.35B | 55.78B | 44.88B | 53.46B | 67.43B | 93.83B |
| Investing Cash Flow | -50.46B | -47.89B | -107.10B | -55.53B | -150.16B | -14.79B |
| Financing Cash Flow | -9.43B | -4.61B | 85.99B | -58.76B | -29.60B | -20.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $720.96B | 25.82 | 13.68% | 1.10% | 21.48% | 65.56% | |
76 Outperform | $1.27T | 22.38 | 8.05% | 1.61% | 0.96% | 3.22% | |
75 Outperform | $1.23T | 23.58 | 10.54% | 1.56% | 3.92% | 9.99% | |
74 Outperform | $553.22B | 37.95 | 4.46% | 2.26% | 3.97% | -41.79% | |
72 Outperform | $698.52B | 23.17 | 8.09% | 2.37% | 11.18% | -0.75% | |
68 Neutral | $875.30B | 26.77 | 4.20% | 2.45% | 3.51% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
OMRON Corporation’s Board of Directors has initiated discussions to spin off its Device & Module Solutions Business (DMB) by April 1, 2026. This move aims to establish an independent management structure for DMB to enhance agility, cost-competitiveness, and investment in new product development, amidst growing market demand and competitive pressures.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen4232.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
OMRON Corporation is a global leader in the industrial automation and healthcare sectors, known for its innovative solutions in automation, sensing, and control technology.
OMRON Corporation reported an increase in consolidated revenue and profit in Q1 FY2025, despite challenges from U.S. tariff policies. The Industrial Automation Business (IAB) and Device & Module Solutions Business (DMB) experienced growth, while the Healthcare Business (HCB) faced declines due to a market slowdown in China. The company remains cautious about the future due to ongoing tariff uncertainties but is progressing with initiatives to enhance competitiveness and profitability.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.